Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Akt in Hepatocellular Carcinoma and Its Tumor Microenvironment
Mariam Mroweh, Gaël S. Roth, Thomas Decaens, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1794-1794
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

The transcription factor ChREBP Orchestrates liver carcinogenesis by coordinating the PI3K/AKT signaling and cancer metabolism
Emmanuel Bénichou, Bolaji Seffou, Selin Topçu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 17
Impacts of Oxidative Stress and PI3K/AKT/mTOR on Metabolism and the Future Direction of Investigating Fucoidan-Modulated Metabolism
Jun‐Ping Shiau, Ya-Ting Chuang, Yuan‐Bin Cheng, et al.
Antioxidants (2022) Vol. 11, Iss. 5, pp. 911-911
Open Access | Times Cited: 54
Hijacking and rewiring of host CircRNA/miRNA/mRNA competitive endogenous RNA (ceRNA) regulatory networks by oncoviruses during development of viral cancers
Mohammad Javad Kamali, Mohammad Salehi, Mehrnaz Mostafavi, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 2
Closed Access | Times Cited: 13
Anticancer perspective of 6-shogaol: anticancer properties, mechanism of action, synergism and delivery system
Yaoxia Jia, Li Xing, Xiangqi Meng, et al.
Chinese Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 12
Ultrasound image-guided cancer gene therapy using iRGD dual-targeted magnetic cationic microbubbles
Yao Zhu, Gulzira Arkin, Wei Zeng, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116221-116221
Open Access | Times Cited: 4
Targeting TM4SF1 to overcome immunotherapy resistance in hepatocellular carcinoma
Valerie Chew
Clinical and Molecular Hepatology (2025)
Open Access
Prediction of Multi-targeting Pharmacological Activity of Bioactive Compounds from Medicinal Plants Against Hepatocellular Carcinoma Through Advanced Network Pharmacology and Bioinformatics-Based Investigation
Hema Priya Manivannan, Vishnu Priya Veeraraghavan, Arul Prakash Francis
Applied Biochemistry and Biotechnology (2025)
Closed Access
Hypoxia reduces SLC27A5 to promote hepatocellular carcinoma proliferation by repressing HNF4A
Junji Tao, Yuanyuan Liu, Xin Tang, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2025) Vol. 1872, Iss. 3, pp. 119916-119916
Closed Access
Computational Network Pharmacology, Molecular Docking, and Molecular Dynamics to Decipher Natural Compounds of Alchornea laxiflora for Liver Cancer Chemotherapy
Nem Kumar Jain, Balakumar Chandrasekaran, Nasha’t Khazaleh, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 508-508
Open Access
Loss of hepatic FTCD promotes lipid accumulation and hepatocarcinogenesis by upregulating PPARγ and SREBP2
Siying Wang, Yangyang Zhou, Ruobing Yu, et al.
JHEP Reports (2023) Vol. 5, Iss. 10, pp. 100843-100843
Open Access | Times Cited: 10
Exploring a novel thiazole derivatives hybrid with fluorinated-indenoquinoxaline as dual inhibitors targeting VEGFR2/AKT and apoptosis inducers against hepatocellular carcinoma with docking simulation
Moustafa S. Abusaif, Ahmed Ragab, Eman A. Fayed, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 108023-108023
Closed Access | Times Cited: 3
Non‐coding RNA‐associated competitive endogenous RNA regulatory networks: Novel diagnostic and therapeutic opportunities for hepatocellular carcinoma
Sattar Khashkhashi-Moghadam, Babak Bakhshinejad, Ali Khalafizadeh, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 26, Iss. 2, pp. 287-305
Open Access | Times Cited: 22
The Research Progress of Bufalin in the Treatment of Hepatocellular Carcinoma
Hanyu Jiang, Huimin Zheng, Cheng Xia, et al.
OncoTargets and Therapy (2022) Vol. Volume 15, pp. 291-298
Open Access | Times Cited: 13
Biomarker Discovery for Hepatocellular Carcinoma in Patients with Liver Cirrhosis Using Untargeted Metabolomics and Lipidomics Studies
Md. Mamunur Rashid, Rency S. Varghese, Yuansong Ding, et al.
Metabolites (2023) Vol. 13, Iss. 10, pp. 1047-1047
Open Access | Times Cited: 7
Circular RNA hsa_circ_0062682 Binds to YBX1 and Promotes Oncogenesis in Hepatocellular Carcinoma
Rok Razpotnik, Robert Vidmar, Marko Fonovič, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4524-4524
Open Access | Times Cited: 11
Discovering Deleterious Single Nucleotide Polymorphisms of Human AKT1 Oncogene: An In Silico Study
Ruojun Zhang, Nahid Akhtar, Atif Khurshid Wani, et al.
Life (2023) Vol. 13, Iss. 7, pp. 1532-1532
Open Access | Times Cited: 6
Synthetic Tryptanthrin Derivatives Induce Cell Cycle Arrest and Apoptosis via Akt and MAPKs in Human Hepatocellular Carcinoma Cells
Jing-Yan Gao, Chih‐Shiang Chang, Jin‐Cherng Lien, et al.
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1527-1527
Open Access | Times Cited: 13
Effect of Novel AKT Inhibitor Vevorisertib as Single Agent and in Combination with Sorafenib on Hepatocellular Carcinoma in a Cirrhotic Rat Model
Keerthi Kurma, Ayça Zeybek Kuyucu, Gaël S. Roth, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 16206-16206
Open Access | Times Cited: 8
Copine 1 predicts poor clinical outcomes by promoting M2 macrophage activation in ovarian cancer
Bo Sheng, Bo Zhao, Yue Dong, et al.
Carcinogenesis (2023) Vol. 44, Iss. 10-11, pp. 748-759
Open Access | Times Cited: 4
Network pharmacology-based study on apigenin present in the methanolic fraction of leaves extract of Cestrum nocturnum L. to uncover mechanism of action on hepatocellular carcinoma
Pradeep Kumar, Amit Kumar Singh, Pooja Verma, et al.
Medical Oncology (2022) Vol. 39, Iss. 10
Closed Access | Times Cited: 7
Hepatocellular carcinoma (HCC): the most promising therapeutic targets in the preclinical arena based on tumor biology characteristics
Haichuan Wang, Xin Chen, Diego F. Calvisi
Expert Opinion on Therapeutic Targets (2021) Vol. 25, Iss. 8, pp. 645-658
Open Access | Times Cited: 9
Deregulated 14-3-3ζ and methionine adenosyltransferase α1 interplay promotes liver cancer tumorigenesis in mice and humans
Liqing Lu, Jing Zhang, Wei Fan, et al.
Oncogene (2021) Vol. 40, Iss. 39, pp. 5866-5879
Open Access | Times Cited: 8
Cannabis sativa demonstrates anti-hepatocellular carcinoma potentials in animal model: in silico and in vivo studies of the involvement of Akt
Dorcas Ibukun Akinloye, Damilohun Samuel Metibemu, Mujidat T. Shittu, et al.
Journal of Cannabis Research (2023) Vol. 5, Iss. 1
Open Access | Times Cited: 3
Zinc fingers and homeoboxes 2 is required for diethylnitrosamine‐induced liver tumor formation in C57BL/6 mice
Jieyun Jiang, Courtney Turpin, Guofang Qiu, et al.
Hepatology Communications (2022) Vol. 6, Iss. 12, pp. 3550-3562
Open Access | Times Cited: 5
Persistent mTORC1 activation via Depdc5 deletion results in spontaneous hepatocellular carcinoma but does not exacerbate carcinogen- and high-fat diet-induced hepatic carcinogenesis in mice
Lin Xu, Chenyan Yang, Jing Wang, et al.
Biochemical and Biophysical Research Communications (2021) Vol. 578, pp. 142-149
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top